C4 Therapeutics Eulerpool Ziņas

C4 Therapeutics Akciju Ziņas

C4 Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās C4 Therapeutics ziņas mēs apkopojam šeit.

• 20. novembris ·

  Yahoo
  C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
• 6. novembris ·

  SeekingAlpha
  C4 Therapeutics: Holding Fast To A Generous Valuation Heading Into An Important ASH Readout
• 6. novembris ·

  Yahoo
  C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
• 5. novembris ·

  Yahoo
  C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
• 1. novembris ·

  Yahoo
  C4 Therapeutics Third Quarter 2024 Earnings: Beats Expectations
• 1. novembris ·

  TipRanks
  Analysts’ Top Healthcare Picks: C4 Therapeutics (CCCC), Alnylam Pharma (ALNY)
• 31. oktobris ·

  TipRanks
  C4 Therapeutics Advances in Protein Degradation Therapy
• 31. oktobris ·

  Yahoo
  C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
• 31. oktobris ·

  Seeking Alpha
  C4 Therapeutics GAAP EPS of -$0.35 beats by $0.05, revenue of $15.36M beats by $10.76M
• 31. oktobris ·

  GuruFocus
  C4 Therapeutics (CCCC) Q3 2024 Earnings: Revenue Surges to $15.4M, GAAP EPS Loss Narrows to $0.35